- Notice of 4th EOGM
- 4th EOGM Proxy Form
- AGP authorized to acquire selected products of Viartis commercialized in Pakistan under brands previously owned by Pfizer Inc.
- E – Dividend Mandate Form
- Form of Proxy 2022 – English
- Form of Proxy 2022 – Urdu
- Standard Request Form
- Notice of Corporate Briefing Session
- Corporate Briefing Session (CBS)
- Material Information Disclosure – Acquisition Sandoz brands
- AGP authorized to acquire selected products of Sandoz brand in Pakistan
- Notice of Interim dividend and book closure – English
SECP Investor Complaint
SECP’S SERVICE DESK MANAGEMENT SYSTEM
DISCLAIMER: In case your complaint has not been properly redressed by us, you may lodge your complaint with Securities and Exchange Commission of Pakistan (the “SECP”). However, please note that SECP will entertain only those complaints which were at first directly requested to be redressed by the Company and the company has failed to redress the same. Further, the complaints that are not relevant to SECP’s regulatory domain/competence shall not be entertained by the SECP.